Search research articles
Contact Us
Filters
Showing results (141-150 of 162) with videos related to
Page
of 17
Sort By:
Genes & Development
|
May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stress
Gabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Pharmacological Research
|
January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
Laura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
The EMBO Journal
|
February 27, 2025
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer
Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, et al.
Gut
|
May 31, 2024
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
Markus Vogt, Nevenka Dudvarski Stankovic, Yiliam Cruz Garcia, et al.
Molecular Cell
|
April 1, 2019
MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation
Apoorva Baluapuri, Julia Hofstetter, Nevenka Dudvarski Stankovic, et al.
Cell Death and Differentiation
|
May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescence
Markus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Cancer Discovery
|
April 4, 2014
Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D
Sandra Baumgart, Nai-Ming Chen, Jens T Siveke, et al.
Nature Communications
|
February 22, 2019
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M Haikala, Johanna M Anttila, Elsa Marques, et al.
Nature Communications
|
February 8, 2019
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M Haikala, Johanna M Anttila, Elsa Marques, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 162) with videos related to
Sort By:
Page
of 17
Genes & Development
|
May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stress
Gabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Pharmacological Research
|
January 19, 2025
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
Laura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
The EMBO Journal
|
February 27, 2025
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer
Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, et al.
Gut
|
May 31, 2024
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2
Markus Vogt, Nevenka Dudvarski Stankovic, Yiliam Cruz Garcia, et al.
Molecular Cell
|
April 1, 2019
MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation
Apoorva Baluapuri, Julia Hofstetter, Nevenka Dudvarski Stankovic, et al.
Cell Death and Differentiation
|
May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescence
Markus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Cancer Discovery
|
April 4, 2014
Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D
Sandra Baumgart, Nai-Ming Chen, Jens T Siveke, et al.
Nature Communications
|
February 22, 2019
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M Haikala, Johanna M Anttila, Elsa Marques, et al.
Nature Communications
|
February 8, 2019
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Heidi M Haikala, Johanna M Anttila, Elsa Marques, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Page
of 17